Shanghai Hansoh Biomedical Co., Ltd clinical trials
A subsidiary of Hansoh Pharmaceutical Group Company Limited
The registry lists 4 studies whose lead sponsor is Shanghai Hansoh Biomedical Co., Ltd. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 14, 2025.
Registry sponsor names on this page
- Shanghai Hansoh Biomedical Co., Ltd4 studies
Something wrong with this grouping? Tell us on the Hansoh Pharmaceutical Group Company Limited page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Hansoh Pharmaceutical Group Company Limited studies →
- Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung CancerNot yet recruitingNCT07063407Phase 1
Sponsor listed in the registry: Shanghai Hansoh Biomedical Co., Ltd
- A Study of HS-20089 in Patients With Advanced Solid TumorsRecruitingNCT05263479Phase 1
Sponsor listed in the registry: Shanghai Hansoh Biomedical Co., Ltd
- ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid TumorsStatus unknownNCT05276609Phase 1
Sponsor listed in the registry: Shanghai Hansoh Biomedical Co., Ltd
- Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy AdultsStatus unknownNCT04940845Phase 1
Sponsor listed in the registry: Shanghai Hansoh Biomedical Co., Ltd